Scarica l'app Stockscreener
35.31
0.34%
-0.12
Dopo l'orario di chiusura:
34.50
-0.81
-2.29%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché HROW Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$35.43
Aprire:
$34.31
Volume 24 ore:
343.92K
Relative Volume:
0.47
Capitalizzazione di mercato:
$1.31B
Reddito:
$272.30M
Utile/perdita netta:
$-5.14M
Rapporto P/E:
-215.96
EPS:
-0.1635
Flusso di cassa netto:
$42.76M
1 W Prestazione:
-0.20%
1M Prestazione:
-34.11%
6M Prestazione:
-26.02%
1 anno Prestazione:
+35.55%
Intervallo 1D:
$34.29
$36.51
Intervallo di 1 settimana:
$33.06
$36.51
Portata 52W:
$20.85
$54.85
Harrow Inc Stock (HROW) Company Profile
Nome
Harrow Inc
Settore
Telefono
615.733.4731
Indirizzo
1A BURTON HILLS BLVD, NASHVILLE, CA
Compare HROW vs TAK, ZTS, HLN, TEVA, UTHR
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
HROW
Harrow Inc
|
35.31 | 1.31B | 272.30M | -5.14M | 42.76M | -0.1635 |
TAK
Takeda Pharmaceutical Co Adr
|
18.74 | 59.20B | 29.85B | 776.90M | 4.35B | 0.2408 |
ZTS
Zoetis Inc
|
117.94 | 49.79B | 9.47B | 2.67B | 2.28B | 6.0218 |
HLN
Haleon Plc Adr
|
9.93 | 44.27B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
30.08 | 35.03B | 17.41B | 1.43B | 1.00B | 1.2182 |
UTHR
United Therapeutics Corp
|
564.81 | 24.75B | 3.18B | 1.33B | 1.04B | 27.90 |
Harrow Inc Stock (HROW) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-11 | Iniziato | Cantor Fitzgerald | Overweight |
| 2025-06-12 | Iniziato | BTIG Research | Buy |
| 2025-06-10 | Iniziato | William Blair | Outperform |
| 2025-02-06 | Iniziato | H.C. Wainwright | Buy |
| 2024-12-04 | Reiterato | B. Riley Securities | Buy |
| 2024-04-11 | Iniziato | Craig Hallum | Buy |
| 2022-09-08 | Ripresa | B. Riley Securities | Buy |
| 2021-10-14 | Ripresa | B. Riley Securities | Buy |
| 2021-09-24 | Iniziato | Aegis Capital | Buy |
| 2021-07-02 | Iniziato | Ladenburg Thalmann | Buy |
Mostra tutto
Harrow Inc Borsa (HROW) Ultime notizie
HROW Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
HROW Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Harrow announces $50M add-on senior notes offering - MSN
Harrow outlines $350M–$365M 2026 revenue goal as sales force expansion and pipeline advances fuel momentum - MSN
Institution Moves: Is Harrow Inc attractive for institutional investors2026 Short Interest & AI Forecasted Entry/Exit Points - baoquankhu1.vn
BTIG Maintains Buy on Harrow Health, Inc. (HROW) March 2026 - Meyka
A Major Investor Just Sold $7.8 Million in Harrow Stock -- Is This a Sell Signal? - AOL.com
HROW6348836 Bond Coupon Analysis — Rate & Payments - TradingView
HROW6348836 Bond Risk Analysis - TradingView
HROW Technical Analysis | Trend, Signals & Chart Patterns | HARROW INC (NASDAQ:HROW) - ChartMill
Harrow prices $50M senior unsecured notes due 2030 at 8.625% - MSN
HROW News | HARROW INC (NASDAQ:HROW) - ChartMill
Layoff Watch: Will Harrow Inc stock recover after earnings2026 Retail Activity & Low Drawdown Momentum Ideas - baoquankhu1.vn
Will Harrow Inc benefit from geopolitical trends2026 Fundamental Recap & Reliable Entry Point Trade Alerts - baoquankhu1.vn
Discipline and Rules-Based Execution in HROW Response - Stock Traders Daily
What Harrow (HROW)'s New US$50 Million Senior Notes Offering Means For Shareholders - Yahoo Finance
Harrow Health Expands Senior Notes Offering for Growth - TipRanks
Harrow Raises $50 Million Via Additional 8.625% Senior Notes Due 2030; Signs Purchase Agreement and Indenture - TradingView
Harrow (NASDAQ: HROW) sells $50M of 8.625% notes due 2030 - Stock Titan
Vanguard disaggregates holdings — Harrow Inc (HROW) reports 0 shares - Stock Titan
Opaleye Trims Harrow Stake After Earnings Miss While Debt Risk Rises - Sahm
Craig-Hallum Keeps Their Buy Rating on Harrow Health (HROW) - The Globe and Mail
Is Harrow Inc currently under institutional pressure2026 Trading Volume Trends & AI Driven Price Forecasts - baoquankhu1.vn
HARROW INC (NASDAQ:HROW): A GARP Stock with Strong Growth at a Reasonable Price - ChartMill
HROW6348836 Bond Price and Chart — FINRA:HROW6348836 - TradingView
Harrow Announces Add-On Offering of $50.0 Million of Senior Unsecured Notes to Support Growth - Bitget
Harrow Announces $50 Million Senior Unsecured Notes Offering Due 2030 to Accelerate Growth and Product Development 12 - Minichart
Harrow Health Prices $50 Million Senior Notes Offering - TipRanks
How Investors May Respond To Harrow (HROW) Issuing US$50M In 8.625% Senior Notes For Growth - simplywall.st
Harrow Announces Pricing of $50.0 Million Offering of Senior Unsecured Notes Due 2030 - The Manila Times
Harrow (NASDAQ: HROW) adds $50M to 8.625% 2030 senior notes - Stock Titan
Harrow Health Announces $50 Million Senior Notes Offering - TipRanks
Harrow Announces $50 Million Add-On Offering of 8.625% Senior Unsecured Notes Due 2030 to Support Growth - Minichart
A Major Investor Just Sold $7.8 Million in Harrow Stock -- Is This a Sell Signal? - The Motley Fool
Harrow to Issue Additional $50 Million Debt Offering - marketscreener.com
Harrow launches $50.0M add-on 8.625% senior notes due 2030 for growth initiatives - TradingView
Harrow (NASDAQ: HROW) plans $50M add-on 8.625% 2030 note issue - stocktitan.net
HC Wainwright Issues Positive Outlook for Harrow Earnings - MarketBeat
Harrow Inc Azioni (HROW) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):